Mar 30, 2026 by Seena HassounaGulf Prtroleum Chief Lawyer's Holdings Have Shrunk 91% — Now He's Helping Run the CompanyOperating in the Utica Shale and SCOOP regions, this energy producer reported a notable insider sale amid ongoing portfolio adjustments.
Mar 28, 2026 by Seena HassounaFive9 President's Share Sale Was Half Tax Bill, Half Trading Plan — Not a Red FlagThis cloud software provider for contact centers reported a notable insider sale amid a year of sharply declining share price.
Mar 27, 2026 by Seena HassounaPBF Energy SVP Trimmed His Position — A Recovering Margin Environment Is the Real StoryPBF Energy, a major U.S. refiner, reported significant insider selling amid ongoing option exercises, SEC filings show.
Mar 26, 2026 by Seena HassounaErasca CMO's Direct Stake Hit Zero. Her Options Position Didn'tThis oncology biotech, developing targeted cancer therapies, reported a notable insider sale following a remarkable year for its stock.
Mar 26, 2026 by Seena HassounaBicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks Louder.This Boston biotech innovator in bifunctional cancer therapies reported a notable insider sale, according to recent filings.
Mar 25, 2026 by Seena HassounaInterface VP's Well-Timed Trim Is Worth a Closer LookThis global flooring supplier to commercial clients across key sectors just reported a notable insider sale in its latest SEC filing.
Mar 25, 2026 by Seena HassounaRemitly Director's $522,000 Sale Was Months in the MakingThis digital remittance provider for immigrants saw a key insider trim their stake under a preset trading plan, recent filings show.
Mar 24, 2026 by Seena HassounaA Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the StoryBausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.
Mar 24, 2026 by Seena HassounaTrupanion's CFO Just Sold His Last Share. The Filing Explains WhyThis specialty insurer for pets operates a recurring revenue model; a recent insider sale comes amid a year of share price declines.
Mar 24, 2026 by Seena HassounaIcahn Enterprises Just Added $78 Million in Centuri Shares, but the Real Story Starts EarlierCenturi Holdings delivers utility infrastructure services to regulated gas and electric providers across North America.
Mar 21, 2026 by Seena HassounaBristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
Mar 21, 2026 by Seena HassounaENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to WatchThis clinical-stage biotech develops immunology therapies for autoimmune and inflammatory diseases, with a diverse pipeline underway.
Mar 20, 2026 by Seena HassounaOaktree Knows Distressed Debt. Its Garrett Motion Sale Tells You Something.Garrett Motion designs turbochargers and electric-boosting systems for global automotive manufacturers and aftermarket distributors.
Mar 19, 2026 by Seena HassounaNextech Trims Kymera at a Recent High — think Foolishly before acting.Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.
Mar 18, 2026 by Seena HassounaSignal or Noise: What VR Adviser's Spyre Theraputics Buy MeansSpyre Therapeutics focuses on antibody therapies for inflammatory bowel disease, advancing a pipeline aimed at gastrointestinal health.
Mar 18, 2026 by Seena HassounaAtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.
Mar 18, 2026 by Seena HassounaWhat to Make of VR Adviser's Big Ocular Therapeutix Sell-DownThis ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global markets.
Mar 17, 2026 by Seena HassounaWhat's Behind Naspers's Steady Exit From Remitly?Remitly, a global digital remittance provider, saw significant insider selling as disclosed in recent regulatory filings.
Mar 15, 2026 by Seena HassounaISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Mar 15, 2026 by Seena HassounaCBIZ Insider Sale: Trust Move or Warning Sign?CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
